Merakris Therapeutics, Inc.
Chris Broderick is the Chief Executive Officer at Merakris Therapeutics, Inc. since 2016. As the Founder & President, Chris founded the company to develop evidence-based therapeutic technologies, secured financing for operations, and supported market access strategy. Chris also served as President at the company, aiming to improve patient lives with regenerative tools. As a consultant, Chris led regulatory and quality initiatives for a medical device company. With a background in founding and leading various companies in the biomedical industry, Chris has extensive experience in intellectual property development, regulatory affairs, financial management, and commercial operations. Chris is currently pursuing a Master's of Science in Biomanufacturing from North Carolina State University.
Merakris Therapeutics, Inc.
1 followers
A pioneer in biotechnology, Merakris Therapeutics, based in Research Triangle Park, North Carolina, is a leader in researching, developing, and marketing regenerative healthcare products. We are pioneering commercially scalable biotherapeutic technologies derived from stem cells that promote homeostasis in damaged tissue. Our vision is to improve global patient care and outcomes through the pioneering and innovation of cellular regenerative biotechnologies. Merakris Therapeutics strives to: • Be a leader in the research and development of regenerative medicine. • Deliver effective medical therapies that require fewer treatments and help to improve patient outcomes, while reducing the overall cost of care. • Educate patients and healthcare providers about the benefits of alternative therapies and regenerative medicine in comparison to standard or more invasive treatment options.